Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies

Thomas W. LeBlanc, Walter F. Baile, Susan Eggly, Carma L. Bylund, Sandra Kurtin, Monica Khurana, Rani Najdi, Julie Blaedel, Jeffrey L. Wolf, Rafael Fonseca

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Objectives: To identify factors limiting and facilitating patient-centered communication (PCC) in the United States hematology-oncology setting, with a focus on multiple myeloma (MM), given the limited attention to PCC and rapid pace of change that has taken place in this setting. Methods: A literature search was performed from 2007 to 2017 to identify published articles and congress abstracts related to clinician-patient communication and treatment decision-making in oncology. Search results were evaluated by year of publication and disease area. A thematic assessment was performed to identify factors limiting and promoting PCC for patients with MM and other hematologic malignancies. Results: Of the 6673 publications initially retrieved, 18 exclusively reported findings in patients with hematologic malignancies and were included in this review. We identified three critical, but modifiable, barriers to PCC in the hematologic malignancy setting, including insufficient information exchange, treatment goal misalignment, and discordant role preferences in treatment decision-making. Factors that enhanced interaction quality included educational programs for clinicians and patients. Conclusions: Patients with MM and other hematologic malignancies experience a distinct set of challenges that may affect PCC. Practice Implications: Clinicians have the opportunity to improve patient care by proactively addressing the identified barriers and implementing strategies demonstrated to improve PCC.

Original languageEnglish (US)
JournalPatient Education and Counseling
DOIs
StatePublished - Jan 1 2019

Fingerprint

Hematologic Neoplasms
Multiple Myeloma
Communication
Publications
Decision Making
Hematology
Patient Care
Therapeutics

Keywords

  • Communication
  • Decision-making
  • Hematologic malignancy
  • Multiple myeloma
  • Patient care

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. / LeBlanc, Thomas W.; Baile, Walter F.; Eggly, Susan; Bylund, Carma L.; Kurtin, Sandra; Khurana, Monica; Najdi, Rani; Blaedel, Julie; Wolf, Jeffrey L.; Fonseca, Rafael.

In: Patient Education and Counseling, 01.01.2019.

Research output: Contribution to journalReview article

LeBlanc, Thomas W. ; Baile, Walter F. ; Eggly, Susan ; Bylund, Carma L. ; Kurtin, Sandra ; Khurana, Monica ; Najdi, Rani ; Blaedel, Julie ; Wolf, Jeffrey L. ; Fonseca, Rafael. / Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies. In: Patient Education and Counseling. 2019.
@article{963d9945051040489a3bf4c4f9831e54,
title = "Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies",
abstract = "Objectives: To identify factors limiting and facilitating patient-centered communication (PCC) in the United States hematology-oncology setting, with a focus on multiple myeloma (MM), given the limited attention to PCC and rapid pace of change that has taken place in this setting. Methods: A literature search was performed from 2007 to 2017 to identify published articles and congress abstracts related to clinician-patient communication and treatment decision-making in oncology. Search results were evaluated by year of publication and disease area. A thematic assessment was performed to identify factors limiting and promoting PCC for patients with MM and other hematologic malignancies. Results: Of the 6673 publications initially retrieved, 18 exclusively reported findings in patients with hematologic malignancies and were included in this review. We identified three critical, but modifiable, barriers to PCC in the hematologic malignancy setting, including insufficient information exchange, treatment goal misalignment, and discordant role preferences in treatment decision-making. Factors that enhanced interaction quality included educational programs for clinicians and patients. Conclusions: Patients with MM and other hematologic malignancies experience a distinct set of challenges that may affect PCC. Practice Implications: Clinicians have the opportunity to improve patient care by proactively addressing the identified barriers and implementing strategies demonstrated to improve PCC.",
keywords = "Communication, Decision-making, Hematologic malignancy, Multiple myeloma, Patient care",
author = "LeBlanc, {Thomas W.} and Baile, {Walter F.} and Susan Eggly and Bylund, {Carma L.} and Sandra Kurtin and Monica Khurana and Rani Najdi and Julie Blaedel and Wolf, {Jeffrey L.} and Rafael Fonseca",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.pec.2019.04.028",
language = "English (US)",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies

AU - LeBlanc, Thomas W.

AU - Baile, Walter F.

AU - Eggly, Susan

AU - Bylund, Carma L.

AU - Kurtin, Sandra

AU - Khurana, Monica

AU - Najdi, Rani

AU - Blaedel, Julie

AU - Wolf, Jeffrey L.

AU - Fonseca, Rafael

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objectives: To identify factors limiting and facilitating patient-centered communication (PCC) in the United States hematology-oncology setting, with a focus on multiple myeloma (MM), given the limited attention to PCC and rapid pace of change that has taken place in this setting. Methods: A literature search was performed from 2007 to 2017 to identify published articles and congress abstracts related to clinician-patient communication and treatment decision-making in oncology. Search results were evaluated by year of publication and disease area. A thematic assessment was performed to identify factors limiting and promoting PCC for patients with MM and other hematologic malignancies. Results: Of the 6673 publications initially retrieved, 18 exclusively reported findings in patients with hematologic malignancies and were included in this review. We identified three critical, but modifiable, barriers to PCC in the hematologic malignancy setting, including insufficient information exchange, treatment goal misalignment, and discordant role preferences in treatment decision-making. Factors that enhanced interaction quality included educational programs for clinicians and patients. Conclusions: Patients with MM and other hematologic malignancies experience a distinct set of challenges that may affect PCC. Practice Implications: Clinicians have the opportunity to improve patient care by proactively addressing the identified barriers and implementing strategies demonstrated to improve PCC.

AB - Objectives: To identify factors limiting and facilitating patient-centered communication (PCC) in the United States hematology-oncology setting, with a focus on multiple myeloma (MM), given the limited attention to PCC and rapid pace of change that has taken place in this setting. Methods: A literature search was performed from 2007 to 2017 to identify published articles and congress abstracts related to clinician-patient communication and treatment decision-making in oncology. Search results were evaluated by year of publication and disease area. A thematic assessment was performed to identify factors limiting and promoting PCC for patients with MM and other hematologic malignancies. Results: Of the 6673 publications initially retrieved, 18 exclusively reported findings in patients with hematologic malignancies and were included in this review. We identified three critical, but modifiable, barriers to PCC in the hematologic malignancy setting, including insufficient information exchange, treatment goal misalignment, and discordant role preferences in treatment decision-making. Factors that enhanced interaction quality included educational programs for clinicians and patients. Conclusions: Patients with MM and other hematologic malignancies experience a distinct set of challenges that may affect PCC. Practice Implications: Clinicians have the opportunity to improve patient care by proactively addressing the identified barriers and implementing strategies demonstrated to improve PCC.

KW - Communication

KW - Decision-making

KW - Hematologic malignancy

KW - Multiple myeloma

KW - Patient care

UR - http://www.scopus.com/inward/record.url?scp=85065120543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065120543&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2019.04.028

DO - 10.1016/j.pec.2019.04.028

M3 - Review article

C2 - 31076236

AN - SCOPUS:85065120543

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

ER -